Genomictree Inc.
228760
Ранг среди акций
#19128
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
Цена акции
$6.58
Рыночная капитализация
$161.41M
Изменение (1 день)
-0.63%
Изменение (1 год)
-50.29%
Страна
KR
Торговля Genomictree Inc. (228760)
Категория
Healthcare
История дроблений акций Genomictree Inc. (228760)
Акции Genomictree Inc. (символ: 228760) прошли через 0 дроблений.
Последнее дробление произошло Oct 21, 2026.
Одна акция 228760, купленная до Oct 21, 2026, сейчас соответствует 0 акциям 228760.
Последнее дробление произошло Oct 21, 2026.
Одна акция 228760, купленная до Oct 21, 2026, сейчас соответствует 0 акциям 228760.
Список дроблений акций
| Год | Дробление | Коэффициент | Суммарный коэффициент |
|---|---|---|---|
| Недостаточно данных для указанных дат. | |||
Дробления акций аналогичных компаний или конкурентов
| Компания | Количество дроблений акций | Суммарный коэффициент | Страна |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
